Indo Borax & Chemicals Intrinsic Value
Indo Borax & Chemicals (INDOBORAX) median intrinsic value is ₹662.10 from 9 valuation models (range ₹116–₹828), vs current price ₹331.05 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. For current market price and key ratios, visit INDOBORAX stock price BSE.
INDOBORAX Valuation Methods Summary — DCF, Graham Number & P/E
Indo Borax & Chemicals intrinsic value across 9 models vs current price ₹331.05 — upside/downside and value range per method. Browse INDOBORAX annual financials for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹217.44 | ₹173.95 - ₹260.93 | -34.3% | EPS: ₹18.12, Sector P/E: 12x |
| Book Value Method | asset | ₹827.62 | ₹744.86 - ₹910.38 | +150.0% | Book Value/Share: ₹1290.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹662.10 | ₹595.89 - ₹728.31 | +100.0% | Revenue/Share: ₹906.67, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹662.10 | ₹595.89 - ₹728.31 | +100.0% | EBITDA: ₹72.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹827.62 | ₹662.10 - ₹993.14 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹115.97 | ₹104.37 - ₹127.57 | -65.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹149.31 | ₹134.38 - ₹164.24 | -54.9% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹662.10 | ₹595.89 - ₹728.31 | +100.0% | ROE: 15.5%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹725.21 | ₹652.69 - ₹797.73 | +119.1% | EPS: ₹18.12, BVPS: ₹1290.00 |
INDOBORAX Intrinsic Value vs Market Price — All Valuation Models
Indo Borax & Chemicals fair value range ₹116–₹828 vs current market price ₹331.05 across 9 valuation models. Also explore INDOBORAX stock price history to track price trends across different timeframes.
INDOBORAX Intrinsic Value Analysis — Undervalued or Overvalued?
Indo Borax & Chemicals median intrinsic value ₹662.10, current price ₹331.05 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of INDOBORAX?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Indo Borax & Chemicals (INDOBORAX) is ₹662.10 (median value). With the current market price of ₹331.05, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹115.97 to ₹827.62, indicating ₹115.97 - ₹827.62.
Is INDOBORAX undervalued or overvalued?
Based on our multi-method analysis, Indo Borax & Chemicals (INDOBORAX) appears to be trading below calculated value by approximately 100.0%.
INDOBORAX Financial Health — Key Ratios vs Industry Benchmarks
Indo Borax & Chemicals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 108.33 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 15.5% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 20.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.67x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
INDOBORAX Cash Flow Quality — Operating & Free Cash Flow
Indo Borax & Chemicals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-72 Cr | ₹-76 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹68 Cr | ₹53 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹60 Cr | ₹56 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹12 Cr | ₹12 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹16 Cr | ₹-11 Cr | Positive Operating Cash Flow | 6/10 |